Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption
May 01, 2024•over 1 year ago
Acquiring Company
Quest Diagnostics
Acquired Company
PathAI, Inc.
Description
Quest Diagnostics, a leader in diagnostic information services, has announced a multi-faceted collaboration with PathAI to accelerate the adoption of digital and AI pathology innovations, with the acquisition of select assets of PathAI Diagnostics. This collaboration aims to improve the quality, speed, and efficiency in diagnosing cancer and other diseases, leveraging Quest's oncology expertise and scale with PathAI's AI and digital pathology innovations.
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed